MedPath

Early detection of dementia using brain perfusion SPECT with cognitive stress test

Phase 2
Conditions
mild cognitive impairment (MCI)
mild cognitive impairment
early detection
dementia screening
brain imaging
cognitive stress
perfusion SPECT
Registration Number
TCTR20190811001
Lead Sponsor
Ratchadapiseksompotch Grant, Chulalongkorn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
155
Inclusion Criteria

- Age 55 - 85 years
- No known history of uncontrolled psychiatric disease
- Stable controllable dementia without choline esterase inhibitor adjustment in the past 3 months
- Thai nationality

Exclusion Criteria

- Diseases which affect this study eg.chronic kidney disease (GFR<30 ml/min), chrnic liver disease (Child-Pugh class B), DM (HbA1c>=7mg% ), all types of cancer
- Who cannot perform CT or MRI of the brain
- Those who have dementia etiology from other causes eg. depression, cerebrovascular disease, etc.
- Patients with neurological disease that affects cognition eg. epilepsy, parkinson disease etc.
- Those who cannot read/write/speak Thai language.
- Those who have MRI finding of frank cerebrovascular disease
- Those who have abnormal lab tests: CBC, Bun, Cr, Electrolytes, LFT, metabolic blood test (Thyroid Function Test, folate, B12, lipid profile, FBS, HbA1c), inflammation/infection blood tests (Syphilis, HIV, ESR)
- Mild dementia patients with abnormal special blood test (autoimmune/paraneoplastic panel, antineuronal IgG, anti-TPO, anti-thyroglobulin)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alzheimer&#39;s dementia at 3 years after detection of mild cognitive impairment & SPECT Brain perfusion SPECT
Secondary Outcome Measures
NameTimeMethod
MMSE and MoCA score at 3 years MMSE and MoCA neurophyschological tests
© Copyright 2025. All Rights Reserved by MedPath